MPLNET.com » Test Menu » B-cell IGH Gene Rearrangement by Next Generation Sequencing Client Login | Email | Phone: 1.800.932.2943

B-cell IGH Gene Rearrangement by Next Generation Sequencing

Test Code

M BCELL

Test Synonyms

B-cell gene rearrangement

Associations

B-cell leukemia, Lymphoma

Methodology

Next Generation Sequencing (NGS)

Turnaround Time

10 days

Specimen Requirements

5.0 mL (min. 3.0 mL) whole blood EDTA or Sodium Heparin
3.0 mL (min. 1.0 mL) bone marrow EDTA or Sodium Heparin
5 mm^3 bone marrow core biopsy, fresh tissue or frozen tissue in MPLN RPMI
3.0 mL (min. 2.0 mL) FNA in MPLN RPMI medium
Formalin fixed paraffin embedded tissue
3 slides (3-5 uM) per marker on adhesion glass

Specimen Stability
EDTA whole blood or bone marrow stable at room temperature for 72 hours
Bone marrow biopsy, fresh tissue or FNA in MPLN RPMI at 2-8°C stable for 72 hours
Frozen tissue frozen at 20°C stable indefinitely
Paraffin embedded stable indefinitely at room temperature
Storage & Handling

Frozen tissue, ship on dry ice.
All other specimen types, ship ambient. Protect from extreme temperature with an ice pack. Separate ice pack from specimen.

Causes for Rejection

Improper specimen labeling; Insufficient sample volume; Clotted specimen; Specimen older than 7 days

Reference Range

Immunoglobulin Heavy Chain Gene (IGH) V-J Regions

Description

Evaluation for suspected clonal B-cell lymphoproliferations when morphologic, immunochemical and/or flow cytometry analyses are inconclusive.

References
  1. Berget, E., Molven, A., Løkeland, T., Helgeland, L., & Vintermyr, O. K. (2015). IGHV gene usage and mutational status in follicular lymphoma: Correlations with prognosis and patient age. Leukemia Research, 7(39), 702-708.
  2. Invivoscribe. (2017). LymphoTrack IGH (FR1,FR2,&FR3) Assays -MiSeq. 280377 Rev. E.
  3. Mannu, C., Gazzola, A., Bacci, F., Sabattini, E., Sagramoso, C., Roncolato, F., . . . Artioli. (2011). Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. American Journal of Blood Research, 1(2), 167-174. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301430/
  4. Meier, V. S., Rufle, A., & Gudat, F. (2001). Simultaneous Evaluation of T- and B-Cell Clonality, t(11;14) and t(14;18), in a Single Reaction by a Four-Color Multiplex Polymerase Chain Reaction Assay and Automated High-Resolution Fragment Analysis. The American Journal of Pathology, 159(6), 2031-2043. doi:10.1016/S0002-9440(10)63055-6
  5. Payne, K., Wright, P., Grant, J. W., Huang, Y., Hamoudi, R., Bacon, C. M., . . . Liu, H. (2011). BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma. British Journal of Haematology, 155(1), 84-92. doi:10.1111/j.1365-2141.2011.08803.x
  6. Sah, S., Chen, L., Houghton, J., Kemppainen, J., Marko, A. C., Zeigler, R., & Latham, G. J. (2013). Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies. Genome Medicine, 5(8), 77.
  7. van Dongen, J., Langerak, A., Brüggemann, M., Evans, P., Hummel, M., Lavender, F., . . . Macintyre, E. (2003). Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 17, 2257-2317.
  8. van Krieken, J., Langerak, A., Macintyre, E., Kneba, M., Hodges, E., García-Sanz, R., . . . Van Dongen, J. (2007). Improved reliability of lymphoma diagnostics via PCR-based clonality testing: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia, 21, 201-206.